A detailed history of Manufacturers Life Insurance Company, The transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 89,425 shares of AMRX stock, worth $701,986. This represents 0.0% of its overall portfolio holdings.

Number of Shares
89,425
Previous 94,195 5.06%
Holding current value
$701,986
Previous $598,000 24.41%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$6.42 - $8.83 $30,623 - $42,119
-4,770 Reduced 5.06%
89,425 $744,000
Q2 2024

Aug 14, 2024

BUY
$5.36 - $7.11 $122,476 - $162,463
22,850 Added 32.03%
94,195 $598,000
Q1 2024

May 14, 2024

BUY
$5.24 - $6.34 $113,859 - $137,761
21,729 Added 43.79%
71,345 $432,000
Q4 2023

Feb 13, 2024

SELL
$3.36 - $6.21 $4,939 - $9,128
-1,470 Reduced 2.88%
49,616 $301,000
Q3 2023

Nov 15, 2023

SELL
$2.76 - $4.59 $632 - $1,051
-229 Reduced 0.45%
51,086 $215,000
Q2 2023

Aug 11, 2023

BUY
$1.33 - $3.1 $9,298 - $21,672
6,991 Added 15.77%
51,315 $159,000
Q4 2022

Aug 11, 2023

SELL
$1.96 - $2.61 $5,419 - $7,216
-2,765 Reduced 5.87%
44,324 $88,000
Q4 2022

Feb 13, 2023

SELL
$1.96 - $2.61 $5,419 - $7,216
-2,765 Reduced 5.87%
44,324 $88,000
Q3 2022

Aug 11, 2023

SELL
$2.02 - $3.62 $1,046 - $1,875
-518 Reduced 1.09%
47,089 $95,000
Q3 2022

Nov 03, 2022

SELL
$2.02 - $3.62 $1,046 - $1,875
-518 Reduced 1.09%
47,089 $95,000
Q2 2022

Aug 11, 2023

BUY
$3.01 - $4.46 $2,739 - $4,058
910 Added 1.95%
47,607 $151,000
Q2 2022

Aug 15, 2022

BUY
$3.01 - $4.46 $2,739 - $4,058
910 Added 1.95%
47,607 $151,000
Q1 2022

Aug 11, 2023

BUY
$3.9 - $4.89 $9,254 - $11,603
2,373 Added 5.35%
46,697 $194,000
Q1 2022

May 20, 2022

SELL
$3.9 - $4.89 $42,712 - $53,555
-10,952 Reduced 19.0%
46,697 $195,000
Q4 2021

Feb 16, 2022

SELL
$3.95 - $5.85 $2,152 - $3,188
-545 Reduced 0.94%
57,649 $276,000
Q3 2021

Nov 12, 2021

SELL
$4.31 - $5.64 $13,468 - $17,625
-3,125 Reduced 5.1%
58,194 $311,000
Q2 2021

Aug 12, 2021

SELL
$5.12 - $6.82 $1,950 - $2,598
-381 Reduced 0.62%
61,319 $314,000
Q1 2021

May 03, 2021

SELL
$4.74 - $7.38 $13,096 - $20,390
-2,763 Reduced 4.29%
61,700 $415,000
Q4 2020

Feb 12, 2021

BUY
$3.95 - $5.42 $2,701 - $3,707
684 Added 1.07%
64,463 $295,000
Q2 2020

Aug 10, 2020

SELL
$2.87 - $5.46 $48,055 - $91,422
-16,744 Reduced 20.79%
63,779 $298,000
Q1 2020

May 15, 2020

BUY
$2.46 - $5.35 $41,915 - $91,158
17,039 Added 26.84%
80,523 $280,000
Q4 2019

Feb 14, 2020

SELL
$2.65 - $5.56 $1,325 - $2,780
-500 Reduced 0.78%
63,484 $306,000
Q3 2019

Nov 12, 2019

BUY
$2.29 - $7.1 $1,039 - $3,223
454 Added 0.71%
63,984 $205,000
Q2 2019

Aug 14, 2019

BUY
$6.44 - $14.29 $13,994 - $31,052
2,173 Added 3.54%
63,530 $456,000
Q1 2019

May 13, 2019

BUY
$11.87 - $14.84 $96,052 - $120,085
8,092 Added 15.19%
61,357 $869,000
Q4 2018

Feb 14, 2019

SELL
$13.09 - $21.49 $51,404 - $84,391
-3,927 Reduced 6.87%
53,265 $721,000
Q3 2018

Nov 14, 2018

SELL
$16.4 - $24.27 $123,131 - $182,219
-7,508 Reduced 11.6%
57,192 $1.27 Million
Q2 2018

Aug 14, 2018

BUY
$13.95 - $20.2 $902,565 - $1.31 Million
64,700 New
64,700 $1.06 Million

Others Institutions Holding AMRX

About Amneal Pharmaceuticals, Inc.


  • Ticker AMRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 151,408,992
  • Market Cap $1.19B
  • Description
  • Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...
More about AMRX
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.